THEMISMED

THEMIS MEDICARE

Small Cap BSE: 530199 NSE: THEMISMED
₹1009.00
2.15 (0.21%)
As on 30 September, 2022 | 02:55

Themis Medicare Share Price

Themis Medicare Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in THEMIS MEDICARE

Start SIP

Themis Medicare Share Returns

  • Over 1 Month 22.28%
  • Over 3 Month 33.7%
  • Over 6 Month 7.53%
  • Over 1 Year 1.06%

Themis Medicare Key Statistics

P/E Ratio 15.7
PEG Ratio -148.9
Market Cap Cr 928
Price to Book Ratio 3.2
EPS 66.9
Dividend 0.5
Relative Strength Index 61.05
Money Flow Index 83.82
MACD Signal 50.54
Average True Range 59.22

Themis Medicare Investment Rating

  • Master Rating:
  • Themis Medicare has an operating revenue of Rs. 376.55 Cr. on a trailing 12-month basis. An annual revenue growth of 71% is outstanding, Pre-tax margin of 21% is great, ROE of 25% is exceptional. The company has a reasonable debt to equity of 8%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 17% and 11% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart but failed to keep its momentum and is trading around -11% from the pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 81 which is a GOOD score indicating consistency in earnings, a RS Rating of 63 which is FAIR indicating the recent price performance, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 124 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Themis Medicare Financials
IndicatorJun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 94809510711362
Operating Expenses Qtr Cr 746578847249
Operating Profit Qtr Cr 201417234013
Depreciation Qtr Cr 222222
Interest Qtr Cr 222233
Tax Qtr Cr 545491
Net Profit Qtr Cr 1281215277

Themis Medicare Technicals

EMA & SMA

Current Price
1004.05
-2.8 (-0.28%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 957.88
  • 50 Day
  • 891.71
  • 100 Day
  • 872.8
  • 200 Day
  • 900.86
  • 20 Day
  • 941.28
  • 50 Day
  • 863.49
  • 100 Day
  • 825.59
  • 200 Day
  • 900.05

Themis Medicare Resistance and Support

PIVOT
₹1018.29
Resistance
First Resistance 1038.57
Second Resistance 1070.29
Third Resistance 1090.57
RSI 61.05
MFI 83.82
MACD Single Line 50.54
MACD 52.87
Support
First Resistance 986.57
Second Resistance 966.29
Third Resistance 934.57

Themis Medicare Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 5,619 388,722 69.18
Week 18,004 940,910 52.26
1 Month 20,346 930,016 45.71
6 Month 6,025 354,080 58.77

Themis Medicare Result Highlights

Themis Medicare Synopsis

NSE-Medical-Generic Drugs

Themis Medicare Ltd. is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 394.61 Cr. and Equity Capital is Rs. 9.20 Cr. for the Year ended 31/03/2022. Themis Medicare Ltd. is a Public Limited Listed company incorporated on 31/05/1969 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24110GJ1969PLC001590 and registration number is 001590.
Market Cap 924
Sales 377
Shares in Float 0.30
No of funds 1
Yield 0.5
Book Value 3.79
U/D Vol ratio 2.2
LTDebt / Equity 10
Alpha 0.04
Beta 0.8

Themis Medicare

Owner NameJun-22Mar-22Dec-21Sep-21
Promoters 67.18%67.18%67.18%
Foreign Portfolio Investors
Financial Institutions/ Banks 0.01%0.01%0.01%
Individual Investors 22.35%22.2%22.3%
Others 10.46%10.61%10.51%

Themis Medicare Management

Name Designation
Mr. Hoshang Sinor Chairman & Ind.Director
Dr. Dinesh S Patel Executive Vice Chairman
Dr. Sachin D Patel Managing Director & CEO
Mr. Rajneesh Anand Non Executive Director
Mr. Lajos Kovacs Non Executive Director
Dr. Gabor Gulacsi Non Executive Director
Mr. Vijay G Agarwal Independent Director
Mr. Hariharan Subramaniam Independent Director
Ms. Manjul Sandhu Independent Director
Mr. Bhaskar V Iyer Independent Director
Mrs. Reena S Patel Alternate Director

Themis Medicare Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Themis Medicare Corporate Action

Date Purpose Remarks
2022-07-28 Quarterly Results
2022-05-21 Audited Results & Final Dividend
2022-02-11 Quarterly Results
2021-11-12 Quarterly Results
2021-08-13 Quarterly Results

Themis Medicare MF Shareholding

Name Amount(cr)
Motilal Oswal S&P BSE Healthcare ETF 6

Themis Medicare FAQs

What is Share Price of Themis Medicare ?

Themis Medicare share price is ₹1009 As on 30 September, 2022 | 02:41

What is the Market Cap of Themis Medicare ?

The Market Cap of Themis Medicare is ₹928.3 Cr As on 30 September, 2022 | 02:41

What is the P/E ratio of Themis Medicare ?

The P/E ratio of Themis Medicare is 15.7 As on 30 September, 2022 | 02:41

What is the PB ratio of Themis Medicare ?

The PB ratio of Themis Medicare is 3.2 As on 30 September, 2022 | 02:41

Q1FY23